ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARGARET RILEY M.D.

Psychiatry

4,514

$492K

206
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$109
Average prescription price

Avg: $110

KALPANA ACHARYA MD

Psychiatry

4,485

$594K

225
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$133
Average prescription price

Avg: $110

ALOYSIUS DAVIS M.D.

Psychiatry

4,407

$642K

374
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$146
Average prescription price

Avg: $110

YOSHIHARU AKABANE MD.

Psychiatry

4,381

$477K

197
63 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$109
Average prescription price

Avg: $110

PAMELA HOYT MD

Psychiatry

4,364

$447K

243
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

RICHARD LISTERUD M.D.

Psychiatry

4,358

$363K

278
38 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$83
Average prescription price

Avg: $110

SUBHA THIAGARAJAN M.D.

Psychiatry

4,316

$482K

313
42 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$112
Average prescription price

Avg: $110

ALEXANDRA ACCARDI MD

Psychiatry

4,273

$438K

360
90 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

KAMEL GHERBI M.D

Psychiatry

4,179

$633K

183
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$152
Average prescription price

Avg: $110

RALPH TALBOT

Psychiatry

4,176

$261K

172
38 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$62
Average prescription price

Avg: $110

PAUL EPSTEIN MD

Psychiatry

4,126

$563K

193
73 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 20%

$136
Average prescription price

Avg: $110

ELLEN KANTER M.D.

Psychiatry

4,110

$323K

157
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$79
Average prescription price

Avg: $110

GUILLERMO GONZALEZ MD

Psychiatry

4,072

$252K

299
66 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 20%

$62
Average prescription price

Avg: $110

MEERA RUPAREL M.D.

Psychiatry

3,998

$415K

205
46 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$104
Average prescription price

Avg: $110

THOMAS WEISS M.D.

Psychiatry

3,967

$432K

163
14 are 65+

20%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$109
Average prescription price

Avg: $110

SUSAN REUBEN M.D.

Psychiatry

3,921

$580K

237
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$148
Average prescription price

Avg: $110

ALICE MARY GRAHAM-BROWN M.D.

Psychiatry

3,901

$352K

246
43 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$90
Average prescription price

Avg: $110

PETER GHERARDI M.D.

Psychiatry

3,867

$479K

242
25 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$124
Average prescription price

Avg: $110

MARC WHALEY M.D.

Psychiatry

3,847

$596K

185
104 are 65+

28%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 20%

$155
Average prescription price

Avg: $110

STEPHEN DUBIN DO

Psychiatry

3,846

$440K

209
77 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 20%

$114
Average prescription price

Avg: $110

JANET KENNEDY M.D.

Psychiatry

3,811

$532K

161
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$140
Average prescription price

Avg: $110

JING PATRINOSTRO MD

Psychiatry

3,806

$398K

285
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $110

ANDREA STONE M.D.

Psychiatry

3,772

$441K

191
23 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$117
Average prescription price

Avg: $110

MARIA VERA MENEZES M.D.

Psychiatry

3,703

$470K

239
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$127
Average prescription price

Avg: $110

ANTHONY TABACCO M.D.

Psychiatry

3,674

$401K

155
21 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$109
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank